Skip to main content
. 2021 Jun 21;25(9):1876–1897. doi: 10.1002/ejp.1811

FIGURE 3.

FIGURE 3

Risk of bias summary: review authors' judgments about each risk of bias item for each included study. Performance bias was overall high (89%) as a result of the difficulties in blinding no‐treatment groups. The item ‘carry‐over effect for cross‐over studies' was scored frequently (94%) as ‘unclear risk’ due to the low amount of cross‐over trials (k = 1)